Viewing Study NCT04360005


Ignite Creation Date: 2025-12-25 @ 3:27 AM
Ignite Modification Date: 2025-12-26 @ 2:08 AM
Study NCT ID: NCT04360005
Status: AVAILABLE
Last Update Posted: 2025-12-05
First Post: 2020-04-21
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Managed Access Programs for ABL001, Asciminib
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module